Maleimide conjugated PEGylated liposomal antibiotic to combat multi-drug resistant Escherichia coli and Klebsiella pneumoniae with enhanced wound healing potential-Reference-Cited by-同舟云学术

Maleimide conjugated PEGylated liposomal antibiotic to combat multi-drug resistant Escherichia coli and Klebsiella pneumoniae with enhanced wound healing potential

Published:2024-08-07 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ladva Darshan Narendrabhai,Selvadoss Pradeep Pushparaj,Chitroda Grishma Kantibhai,Dhanasekaran Sivaraman,Nellore Jayshree,Tippabathani Jayakrishna,Solomon Sundar Manoharan

Funder

Ministry of Education, India

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-68647-6.pdf

Reference45 articles.

1. WHO. Global Antimicrobial Resistance and use Surveillance System (GLASS) Report 2022. Report No. CC BY-NC-SA 3.0 IGO, (2022).

2. Allcock, S. et al. Antimicrobial resistance in human populations: Challenges and opportunities. Glob. Health Epidemiol. Genom. 2, e4. https://doi.org/10.1017/gheg.2017.4 (2017).

3. Mogasale, V. V., Saldanha, P., Pai, V., Rekha, P. D. & Mogasale, V. A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India. Sci. Rep. 11, 5116. https://doi.org/10.1038/s41598-021-84293-8 (2021).

4. Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H. & Fishman, N. O. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32, 1162–1171. https://doi.org/10.1086/319757 (2001).

5. Muteeb, G. Nanotechnology—A light of hope for combating antibiotic resistance. Microorganisms 11, 1489 (2023).